MetaCap

Cypherpunk Technologies Inc. (CYPH)

NASDAQ: CYPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.41-0.31 (-18.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CYPH stock chart

Technical analysis

Key statistics

All statistics
Market cap
$210.15M
52-week range
0.491 – 4.19
Day range
1.37 – 1.66
Volume / Avg
16.17M / 15.42M
Beta
—

52-week range

$0.491$4.19

CYPH stock today

Cypherpunk Technologies (CYPH) closed at $1.41 on Nov 20, down 18.02% (-$0.31), versus the S&P 500's 3.70% decline. At this level, CYPH sits in the middle of its 52-week range of $0.491 to $4.19: 66.3% below the high, set on Sep 25, 2026 and 187.2% above the low. CYPH is up 21.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 38.2%.

Cypherpunk Technologies trades at 0.7x its trailing twelve-month earnings per share of $2.09.

Summary generated from market data by MetaCap's automated system. Methodology

About Cypherpunk Technologies

Company profile

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Douglas E. Onsi J.D.
Headquarters
Cambridge, MA
Employees
6

Financial highlights

Full financials

Net income was $4.8 million. Diluted earnings per share came in at $0.07.

Cypherpunk Technologies annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue————$1.50M
Growth————0.00%
Net income$4.82M$-67.56M$-81.41M$-54.60M$-40.59M
EPS (diluted)$0.07$-1.81$-3.98$-4.82$-0.47

Analyst forecast

Forecast

Consensus (1 analysts)

strong_buy

Avg. price target

$5.00+254.61%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 16, 2026
EPS actual vs est.
$-0.09 vs —

CYPH news

All CYPH news

Cypherpunk Technologies peers

Health Care sector
CYPH peer companies
CompanyPrice% ChgMarket capCompare
VNDAVanda Pharmaceuticals Inc.3.45-6.13%$208.32Mvs CYPH
ARCTArcturus Therapeutics Holdings Inc.7.45-1.97%$214.73Mvs CYPH
PYXSPyxis Oncology Inc.1.81+7.74%$216.49Mvs CYPH
FTHFaeth Therapeutics Inc.7.88-9.32%$203.65Mvs CYPH
BCYCBicycle Therapeutics plc ADR2.90-4.92%$203.27Mvs CYPH
KROSKeros Therapeutics Inc.11.08-2.72%$217.44Mvs CYPH
RCKTRocket Pharmaceuticals Inc.1.95-7.58%$217.74Mvs CYPH
IMRXImmuneering Corporation Class A3.38-2.03%$218.90Mvs CYPH

Indexes, lists and sector

Cypherpunk Technologies stock FAQ

What is Cypherpunk Technologies's stock price today?

CYPH last traded at $1.41 as of Nov 20, 4:00 PM EST, down 18.02% on the day. Prices are delayed at least 15 minutes.

Does Cypherpunk Technologies pay a dividend?

No. Cypherpunk Technologies does not currently pay a regular cash dividend.

What is CYPH's P/E ratio?

CYPH trades at a trailing P/E ratio of 0.67.

Who is Cypherpunk Technologies's CEO?

Mr. Douglas E. Onsi J.D. is the chief executive officer of Cypherpunk Technologies Inc., which has about 6 employees.

Has CYPH ever split its stock?

Yes. The most recent CYPH stock split was a 1-for-10 split on Jun 21, 2023.

What is the CYPH 52-week high?

The 52-week high for CYPH is $4.19 and the 52-week low is $0.491. The stock is currently 66.3% below its high.

Compare CYPH